tradingkey.logo

Zynex Inc

ZYXI
查看詳細走勢圖
0.125USD
0.000
收盤 12/24, 13:00美東報價延遲15分鐘
3.86M總市值
虧損本益比TTM

Zynex Inc

0.125
0.000
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

-52.62%

1月

-82.88%

6月

-95.00%

今年開始到現在

-98.44%

1年

-98.45%

查看詳細走勢圖

TradingKey Zynex Inc股票評分

單位: USD 更新時間: 2025-12-23

操作建議

Zynex Inc當前公司基本面數據相對穩定,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名123/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價2.85。中期看,股價處於下降通道。近一個月,市場表現非常差,基本面和技術面綜合得分也較低。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Zynex Inc評分

相關信息

行業排名
123 / 208
全市場排名
296 / 4568
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 2 分析師
買入
評級
2.850
目標均價
+251.90%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Zynex Inc亮點

亮點風險
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
業績高增長
公司營業收入穩步增長,連續3年增長21.61%
估值低估
公司最新PE估值-0.05,處於3年歷史低位
機構減倉
最新機構持股4.98M股,環比減少51.57%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉199.56K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.99

Zynex Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Zynex Inc簡介

Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
公司代碼ZYXI
公司Zynex Inc
CEODyson (Steven Lewis)
網址https://www.zynex.com/

常見問題

Zynex Inc(ZYXI)的當前股價是多少?

Zynex Inc(ZYXI)的當前股價是 0.125。

Zynex Inc 的股票代碼是什麼?

Zynex Inc的股票代碼是ZYXI。

Zynex Inc股票的52週最高點是多少?

Zynex Inc股票的52週最高點是8.450。

Zynex Inc股票的52週最低點是多少?

Zynex Inc股票的52週最低點是0.178。

Zynex Inc的市值是多少?

Zynex Inc的市值是3.86M。

Zynex Inc的淨利潤是多少?

Zynex Inc的淨利潤為2.99M。

現在Zynex Inc(ZYXI)的股票是買入、持有還是賣出?

根據分析師評級,Zynex Inc(ZYXI)的總體評級為買入,目標價格為2.850。

Zynex Inc(ZYXI)股票的每股收益(EPS TTM)是多少

Zynex Inc(ZYXI)股票的每股收益(EPS TTM)是-2.407。
KeyAI